Country: Ավստրալիա
language: անգլերեն
source: Department of Health (Therapeutic Goods Administration)
ciprofloxacin hydrochloride, Quantity: 589.172 mg (Equivalent: ciprofloxacin, Qty 500 mg)
Arrotex Pharmaceuticals Pty Ltd
ciprofloxacin hydrochloride
Tablet, film coated
Excipient Ingredients: povidone; sodium starch glycollate type A; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; macrogol 400
Oral
14, 60, 28
(S4) Prescription Only Medicine
Ciprofloxacin is indicated for the treatment of infections caused by susceptible organisms in the conditions listed below: Urinary tract infections; Gonorrhoeal urethritis and cervicitis; Gastroenteritis; Bronchial Infections; Skin and skin structure infections; Bone and joint infections; Chronic bacterial prostatitis of mild to moderate severity. Inhalational anthrax (post-exposure): To reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis. Ciprofloxacin serum concentrations achieved in humans serve as a surrogate endpoint reasonably likely to predict clinical benefit and provide the basis for this indication. Note: Typhoid and Paratyphoid infections and infections due to multi-resistant Staphylococcus aureus are excluded from the above due to insufficient data. Because Gram-positive organisms are generally less sensitive to ciprofloxacin, it may not be the drug of choice in cases with Gram-positive infections, such as pneumonia due to Streptococcus pneumoniae. Chronic bacterial prostatitis should be demonstrated by microbiological evidence localising infection to the prostate. Strains of Neisseria gonorrhoea resistant to ciprofloxacin have been reported in Australia. Appropriate culture and susceptibility tests should be performed before treatment in order to determine organism susceptibility to ciprofloxacin and after treatment as warranted by the clinical condition. Therapy with Ciprofloxacin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued. Ciprofloxacin is suitable to treat mixed infections caused by susceptible strains of both Gram-negative and Gram-positive aerobic bacteria. If anaerobic organisms are suspected as accompanying aetiologic agents, additional therapy should be considered.
Visual Identification: White to off-white, capsule shaped, film coated tablets, with a score line on one side and debossed with 'F 22' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2011-12-16
AURO-CIPROFLOXACIN CONSUMER MEDICINE INFORMATION Ver 1.2 Page 1 of 4 AURO-CIPROFLOXACIN 250, 500 & 750 Ciprofloxacin (as hydrochloride) _ _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about AURO- CIPROFLOXACIN tablets. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking AURO- CIPROFLOXACIN tablets against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT AURO-CIPROFLOXACIN IS USED FOR AURO-CIPROFLOXACIN tablets are used for the treatment of infections of the lungs, skin, bones, joints, kidneys, bladder, prostate and bowel. AURO-CIPROFLOXACIN is also used to treat inhalational anthrax (an infection caused by breathing in the spores of bacteria). AURO-CIPROFLOXACIN tablets contain the active ingredient, CIPROFLOXACIN , which is an antibiotic belonging to a group of medicines called quinolones (pronounced kwin- o-lones). These antibiotics work by killing the bacteria that are causing your infection. AURO-CIPROFLOXACIN will not work against infections caused by viruses such as colds or the flu. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. BEFORE YOU TAKE AURO-CIPROFLOXACIN WHEN YOU MUST NOT TAKE IT DO NOT TAKE AURO- CIPROFLOXACIN IF YOU HAVE AN ALLERGY TO: • ciprofloxacin, the active ingredient in AURO- CIPROFLOXACIN • any of the ingredients listed at the end of this leaflet • other medicines belonging to the quinolone chemical family (e.g. moxifloxacin, norfloxacin, nalidixic acid). Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts read_full_document